OTCMKTS:DDXS

(DDXS) Competitors

$0.0001

0.00 (0.00 %)

(As of 12/7/2020)

Add

Compare

Today's Range

$0.00

Now: $0.00▼

$0.00

50-Day Range N/A

52-Week Range

$0.01

Now: $0.00▼

$5.40

Volume30 shs

Average Volume15,481 shs

Market Capitalization$410.00

P/E RatioN/A

Dividend YieldN/A

BetaN/A

(DDXS) (OTCMKTS:DDXS) Vs. TNGN, ATTBF, ADTX, AGNPF, LBTSF, and CBDC

Should you be buying DDXS stock or one of its competitors? Companies in the industry of "biotechnology" are considered alternatives and competitors to (DDXS), including (TNGN) (TNGN), Abattis Bioceuticals (ATTBF), ADiTx Therapeutics (ADTX), Algernon Pharmaceuticals (AGNPF), Almirall (LBTSF), and Apotheca Biosciences (CBDC).

(DDXS) vs. (TNGN) Stock

(DDXS) (OTCMKTS:DDXS) and (TNGN) (OTCMKTS:TNGN) are both health technology companies, but which is the better business? We will compare the two businesses based on the strength of their risk, earnings, profitability, dividends, valuation, analyst recommendations and institutional ownership.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for (DDXS) and (TNGN), as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
(DDXS)	0	0	0	0	N/A
(TNGN)	0	0	0	0	N/A

Profitability

This table compares (DDXS) and (TNGN)'s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
(DDXS)	N/A	N/A	N/A
(TNGN)	N/A	N/A	N/A

Valuation & Earnings

This table compares (DDXS) and (TNGN)'s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
(DDXS)	N/A	N/A	N/A	N/A	N/A
(TNGN)	N/A	N/A	N/A	N/A	N/A

(DDXS) vs. Abattis Bioceuticals Stock

(DDXS) (OTCMKTS:DDXS) and Abattis Bioceuticals (OTCMKTS:ATTBF) are both health technology companies, but which is the better business? We will compare the two businesses based on the strength of their risk, earnings, profitability, dividends, valuation, analyst recommendations and institutional ownership.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for (DDXS) and Abattis Bioceuticals, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
(DDXS)	0	0	0	0	N/A
Abattis Bioceuticals	0	0	0	0	N/A

Profitability

This table compares (DDXS) and Abattis Bioceuticals' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
(DDXS)	N/A	N/A	N/A
Abattis Bioceuticals	N/A	N/A	N/A

Valuation & Earnings

This table compares (DDXS) and Abattis Bioceuticals' gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
(DDXS)	N/A	N/A	N/A	N/A	N/A
Abattis Bioceuticals	N/A	N/A	N/A	N/A	N/A

(DDXS) vs. ADiTx Therapeutics Stock

(DDXS) (OTCMKTS:DDXS) and ADiTx Therapeutics (NASDAQ:ADTX) are both health technology companies, but which is the better business? We will compare the two businesses based on the strength of their risk, earnings, profitability, dividends, valuation, analyst recommendations and institutional ownership.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for (DDXS) and ADiTx Therapeutics, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
(DDXS)	0	0	0	0	N/A
ADiTx Therapeutics	0	0	1	0	3.00

Profitability

This table compares (DDXS) and ADiTx Therapeutics' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
(DDXS)	N/A	N/A	N/A
ADiTx Therapeutics	N/A	N/A	N/A

Valuation & Earnings

This table compares (DDXS) and ADiTx Therapeutics' gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
(DDXS)	N/A	N/A	N/A	N/A	N/A
ADiTx Therapeutics	N/A	N/A	N/A	N/A	N/A

Summary

ADiTx Therapeutics beats (DDXS) on 1 of the 1 factors compared between the two stocks.

(DDXS) vs. Algernon Pharmaceuticals Stock

(DDXS) (OTCMKTS:DDXS) and Algernon Pharmaceuticals (OTCMKTS:AGNPF) are both health technology companies, but which is the better business? We will compare the two businesses based on the strength of their risk, earnings, profitability, dividends, valuation, analyst recommendations and institutional ownership.

Profitability

This table compares (DDXS) and Algernon Pharmaceuticals' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
(DDXS)	N/A	N/A	N/A
Algernon Pharmaceuticals	N/A	N/A	N/A

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for (DDXS) and Algernon Pharmaceuticals, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
(DDXS)	0	0	0	0	N/A
Algernon Pharmaceuticals	0	0	0	0	N/A

Valuation & Earnings

This table compares (DDXS) and Algernon Pharmaceuticals' gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
(DDXS)	N/A	N/A	N/A	N/A	N/A
Algernon Pharmaceuticals	N/A	N/A	N/A	N/A	N/A

(DDXS) vs. Almirall Stock

(DDXS) (OTCMKTS:DDXS) and Almirall (OTCMKTS:LBTSF) are both health technology companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, earnings, profitability, dividends, analyst recommendations, risk and institutional ownership.

Profitability

This table compares (DDXS) and Almirall's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
(DDXS)	N/A	N/A	N/A
Almirall	N/A	N/A	N/A

Analyst Ratings

This is a breakdown of current recommendations for (DDXS) and Almirall, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
(DDXS)	0	0	0	0	N/A
Almirall	0	1	1	0	2.50

Earnings and Valuation

This table compares (DDXS) and Almirall's revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
(DDXS)	N/A	N/A	N/A	N/A	N/A
Almirall	N/A	N/A	N/A	N/A	N/A

Summary

Almirall beats (DDXS) on 1 of the 1 factors compared between the two stocks.

(DDXS) vs. Apotheca Biosciences Stock

(DDXS) (OTCMKTS:DDXS) and Apotheca Biosciences (NASDAQ:CBDC) are both health technology companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, earnings, profitability, dividends, analyst recommendations, risk and institutional ownership.

Profitability

This table compares (DDXS) and Apotheca Biosciences' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
(DDXS)	N/A	N/A	N/A
Apotheca Biosciences	N/A	N/A	N/A

Analyst Ratings

This is a breakdown of current recommendations for (DDXS) and Apotheca Biosciences, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
(DDXS)	0	0	0	0	N/A
Apotheca Biosciences	0	0	0	0	N/A

Earnings and Valuation

This table compares (DDXS) and Apotheca Biosciences' revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
(DDXS)	N/A	N/A	N/A	N/A	N/A
Apotheca Biosciences	N/A	N/A	N/A	N/A	N/A